FdaApplication

BLA 125444

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBioverativ Therapeutics, Inc.
application_typeBLA
approval_date2014-03-28

Products (6)

ProductActive ingredientStrengthDosage form
ALPROLIX—4000IUFor Injection
ALPROLIX—2000IUFor Injection
ALPROLIX—250IUFor Injection
ALPROLIX—1000IUFor Injection
ALPROLIX—500IUFor Injection
ALPROLIX—3000IUFor Injection

6 products